Equibles does not estimate personal net worth.
James D. Swift was last confirmed as Board Member at Pediatrix Medical Group, Inc. (MD) in a filing dated March 28, 2024. Earlier roles on record: CEO at Pediatrix Medical Group, Inc. (MD) until January 12, 2025. Pediatrix Medical Group, Inc. reported in an 8-K filed January 14, 2025 that James D. Swift was terminated as Chief Executive Officer, effective January 12, 2025. The proxy statement of Pediatrix Medical Group, Inc. reports total compensation of $2,775,881 for James D. Swift in fiscal 2025, including a base salary of $54,167. Disclosed compensation is on record for 4 fiscal years. James D. Swift has spoken on 4 earnings calls across 1 company, most recently for Pediatrix Medical Group, Inc. on November 1, 2024. The companies whose calls James D. Swift spoke on are classified in the Healthcare sector.
“Dr. Swift's transition from his role as Chief Executive Officer is a termination without "Cause" pursuant to that certain Third Amended and Restated Employment Agreement, dated April 26, 2023, by and between Dr. Swift and a wholly-owned subsidiary of the Company, and Dr. Swift will receive the benefits thereunder following the execution of a general release of claims in favor of the Company, as described in the Proxy Statement.”
“Also with me today is Kasandra Rossi, our Chief Financial Officer. Our third quarter operating results were modestly ahead of expectations, driven primarily by same unit revenue growth.”
“Also with me today is Marc Richards, our Chief Financial Officer. Our first quarter results were in line with our expectations. Our same-unit revenue growth reflected positive volumes in our hospital-based services with NICU days increasing 2.5%.”
“I just think there continues to be interest among the different subspecialties and primary care specialties in the acquisition market.”
“Yeah, I think that both on the acquisitive side and on the organic growth side we’ve seen in the first quarter, especially on the organic growth side, an acceleration in terms of contracts signed with our hospital partners.”
Start not stated–2024-03-28
Last confirmed by a filing; no departure on record
Start not stated–2025-01-12
Medical Care Facilities · Healthcare
Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Pediatrix Medical Group, Inc. (MD) | Former Chief Executive Officer | $54,167 | $2,775,881 |
| 2024 | Pediatrix Medical Group, Inc. (MD) | Former Chief Executive Officer | $650,000 | $3,301,012 |
| 2023 | Pediatrix Medical Group, Inc. (MD) | Former Chief Executive Officer | $650,000 | $2,237,839 |
| 2022 | Pediatrix Medical Group, Inc. (MD) | Former Chief Executive Officer | $450,000 | $1,374,541 |
